Cargando…

Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice

PURPOSE: Using proteomics to study the effect of semaglutide on cardiac protein expression in obese mice. Assessment of the effect of semaglutide on cardiac function in obese mice. MATERIALS AND METHODS: The mice were randomly divided into three groups: the control group (WC), the high-fat group (WF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Xiaoyu, Yue, Lin, Ban, Jiangli, Ren, Lin, Chen, Shuchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704011/ https://www.ncbi.nlm.nih.gov/pubmed/36452054 http://dx.doi.org/10.2147/JIR.S391859

Ejemplares similares

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2023)

Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
por: Chen, Xing, et al.
Publicado: (2022)

Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice
por: Yue, Lin, et al.
Publicado: (2022)

Effect of high-fat diet and empagliflozin on cardiac proteins in mice
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Association of Triglyceride-Glucose Index and Liver Function Parameters Among Healthy Obese Civil Servants: A Center-Based Study
por: Pan, Xiaoyu, et al.
Publicado: (2022)

An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism
por: Ren, Qingjuan, et al.
Publicado: (2022)

Association of Neutrophil to High-Density Lipoprotein Cholesterol Ratio with Cardiac Ultrasound Parameters and Cardiovascular Risk: A Cross-Sectional Study Based on Healthy Populations
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Phosphorylated proteomics-based analysis of the effects of semaglutide on hippocampi of high-fat diet-induced-obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2023)

UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice
por: Zhu, Ruiyi, et al.
Publicado: (2023)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022)

Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Correlation between Cardiac Ultrasound Index and Cardiovascular Risk in Healthy Obese and Overweight Populations
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Correlation of Obesity and Overweight with Cervical Vascular Function Among Healthy Populations
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Effect of empagliflozin on cytoskeletal repair in the hippocampus of obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2022)

Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review
por: Deng, You, et al.
Publicado: (2022)

The Effect of Silibinin on Protein Expression Profile in White Adipose Tissue of Obese Mice
por: Wang, Fei, et al.
Publicado: (2020)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Correlation Between Fibrinogen/Albumin and Diabetic Peripheral Neuropathy
por: Ban, Jiangli, et al.
Publicado: (2023)

Semaglutide in Obesity: Unmet Needs in Men
por: Jensterle, Mojca, et al.
Publicado: (2023)

Decrease of Cardiac Parkin Protein in Obese Mice
por: Thomas, Amandine, et al.
Publicado: (2020)

Semaglutide for the treatment of overweight and obesity: A review
por: Bergmann, Natasha Chidekel, et al.
Publicado: (2022)

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
por: Quddos, Fatima, et al.
Publicado: (2023)

Semaglutide in renal ischemia-reperfusion injury in mice
por: Tiba, Al-Tameemi, et al.
Publicado: (2023)

Oral Semaglutide
por: Bui, Vinh, et al.
Publicado: (2018)

Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

Association Between Vitamin D Levels and the Atherogenic Index of Plasma Among Chinese with Type 2 Diabetes Mellitus
por: Ban, Jiangli, et al.
Publicado: (2023)

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
por: Garvey, W. Timothy, et al.
Publicado: (2022)

Proteomics study on the effect of silybin on cardiomyopathy in obese mice
por: Wang, Fei, et al.
Publicado: (2021)

Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice
por: Inia, José A., et al.
Publicado: (2023)

Corrigendum: Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
por: Newsome, Philip, et al.
Publicado: (2019)

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
por: Ghusn, Wissam, et al.
Publicado: (2022)

The Relationship Between Non-HDL-C /HDL-C Ratio (NHHR) and Vitamin D in Type 2 Diabetes Mellitus
por: Zhen, Ruoxi, et al.
Publicado: (2023)

Cardiac Expression of Microsomal Triglyceride Transfer Protein Is Increased in Obesity and Serves to Attenuate Cardiac Triglyceride Accumulation
por: Bartels, Emil D., et al.
Publicado: (2009)

Effects of Semaglutide Versus Dulaglutide on Epicardial Fat Thickness in Subjects with Type 2 Diabetes and Obesity
por: Iacobellis, Gianluca, et al.
Publicado: (2020)

New practice in semaglutide on type-2 diabetes and obesity: clinical evidence and expectation
por: Liu, Yalin, et al.
Publicado: (2022)

The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?
por: Jung, Han Na, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ck51tj552gug4k87ej93rbv589